-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $28

Benzinga·05/12/2026 10:46:03
Listen to the news
Stifel analyst Daniel Arias initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Buy rating and announces Price Target of $28.